biote Corp.
BTMD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001819253
In the last 90 days, biote Corp. insiders filed 1 open-market purchase and 0 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $24.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in biote Corp. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1
- +1 vs. Q4 2021
- Shares held
- 151.8K
- +151.8K vs. Q4 2021
- Total value
- $1.50M
- +$1.50M vs. Q4 2021
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $24.8M |
| Q1 2026 | 84 | $20.5M |
| Q4 2025 | 85 | $40.9M |
| Q3 2025 | 87 | $46.6M |
| Q2 2025 | 98 | $66.7M |
| Q1 2025 | 90 | $56.4M |
| Q4 2024 | 94 | $116.5M |
| Q3 2024 | 83 | $99.6M |
| Q2 2024 | 75 | $118.0M |
| Q1 2024 | 54 | $69.5M |
| Q4 2023 | 54 | $62.7M |
| Q3 2023 | 54 | $67.4M |
| Q2 2023 | 55 | $88.2M |
| Q1 2023 | 27 | $42.6M |
| Q4 2022 | 16 | $4.78M |
| Q3 2022 | 16 | $7.69M |
| Q2 2022 | 12 | $2.42M |
| Q1 2022 | 1 | $1.50M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding biote Corp.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schechter Investment Advisors, LLC | 151,828 | $1.50M | 0.14% | +151,828 | New |